Answered on 16 September 2026
Laboratory report of 15 September 2026, 34 markers, drawn fasting on 12 September. Reference ranges from the laboratory; targets from the guidelines. Lab 15.09.2026
Office blood pressure today 138/88 and 136/86 mmHg, seated, after five minutes. BP 16.09.2026
Thirty-four markers, twenty in range, fourteen outside their reference or target. They fall into five decisions, not fourteen. Lab 15.09.2026
- Lipids. LDL 158 mg/dl, non-HDL 190, apolipoprotein B 118, triglycerides 212, HDL 41. With age 44, non-smoker, systolic 138 and non-HDL 190 mg/dl, SCORE2 gives a ten-year risk of around 3 %, which is moderate for his age. At moderate risk the goals are LDL below 100 mg/dl and apolipoprotein B below 100; he is above both. Lab 15.09.2026 BP 16.09.2026
Eur Heart J + 2
- Lipoprotein(a) 92 nmol/l. In the grey zone of 75 to 125 nmol/l. Not high enough to reclassify him on its own, high enough to count as a modifier on top of a moderate risk. It does not need measuring again. Lab 15.09.2026
Eur Heart J
- Sugar. HbA1c 5.8 %, fasting glucose 104 mg/dl: prediabetes by both ADA criteria, for the first time. Fasting insulin 14 µU/ml gives a HOMA-IR of 3.6. With his father's diabetes at 55 and the waist of 101 cm, this is the finding with the most to gain: the Diabetes Prevention Program cut progression to diabetes by 58 % with weight loss and activity. Lab 15.09.2026
Diabetes Care
Diabetologia
N Engl J Med
- Liver. ALT 52 U/l and GGT 78 U/l are raised; AST, bilirubin and albumin are normal. FIB-4 is 0.9, below 1.3, so advanced fibrosis is unlikely. The pattern, with the triglycerides, the waist and two glasses of wine a day, is steatosis; an ultrasound confirms it, and the treatment is the same as for the sugar. Lab 15.09.2026
J Hepatol
Am J Gastroenterol
- Vitamin D 17 ng/ml. Deficient. Supplement, re-test in three months. Lab 15.09.2026
J Clin Endocrinol Metab
What is fine and stays fine: kidney (eGFR 94, albumin-to-creatinine ratio 8 mg/g), thyroid (TSH 2.1), blood count, B12 and folate, iron. Ferritin 186 µg/l is in range but at the upper end; with the liver values it is worth one look in a year, not now. Uric acid 7.4 mg/dl is above the reference and does not need a drug without gout; it falls with the same measures as the rest. hs-CRP 2.6 mg/l is in the average-risk band. Lab 15.09.2026 Kidney Int
Thyroid
WHO
Ann Rheum Dis
Circulation
The tiredness has no single laboratory explanation. Thyroid, iron, B12 and blood count are normal; vitamin D is low; six hours of sleep with snoring is the more likely cause, and it goes on the list for the visit.
- 34 markers, 20 in range, 14 to look at
- Five decisions: lipids, lipoprotein(a), sugar, liver, vitamin D
- The same sheet in his app, in his words
- Laboratory report, prevention panel, 15 September 2026Laboratory
- Office blood pressure, two readings, 16 September 2026Measurement
- 1.SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe.
- 2.2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.
- 3.2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.
- 4.Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement.
- 5.2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2026.
- 6.Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.
- 7.Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.
- 8.EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD).
- 9.ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries.
- 10.Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline.
- 11.KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.
- 12.Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association.
- 13.WHO guideline on use of ferritin concentrations to assess iron status in individuals and populations.
- 14.2016 updated EULAR evidence-based recommendations for the management of gout.
- 15.Markers of inflammation and cardiovascular disease: application to clinical and public health practice. A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.